Biogenomics Limited - Company Profile

Q: Who are the current directors of Biogenomics Limited?

The current directors of Biogenomics Limited are Pushkar Jauhari, Rajesh Shashikant Dalal, Rajiv Malik, Namit Rustagi, Ammar Abdullah Hamad Al Ali, Archana Rajesh Krishnan, Imran Jamiluddin Shaikh, Ali Abdullah Ali Al Aamri, Mohammed Hamdan Saif Al Rubaie, Abhishek Vilas Deshpande, Shilpa Rakesh Shetty.

It is a pharma public limited company based in Pondicherry, Pondicherry, India, established in 2002.

2002 Pondicherry, Pondicherry, India Active

Last Updated: January 05, 2026

Access Report

About Biogenomics Limited

Biogenomics Limited, a active public limited company, was established on 24 April 2002 in Pondicherry, Pondicherry, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24234PY2002PLC009158. Registered under ROC Roc Pondicherry. it is unlisted. It has an authorized capital of ₹390.02 Cr and a paid-up capital of ₹383.51 Cr.

Formerly known as Biogenomics Private Limited. It upholds a compliant status. Employing 193 professional, Its leadership includes Pushkar Jauhari (Nominee Director), Rajesh Shashikant Dalal (Director), Rajiv Malik (Additional Director). Past directors included Pushkar Jauhari, Usama Mohamed Ali Al Barwani, Mohamed Ali Mohamed Al Barwani. It holds ₹3.98 Cr open charges and ₹8.70 Cr settled loans. Its latest AGM occurred on 24 September 2025, with the balance sheet filed on 31 March 2025. It is based at R. S. No. 139, Manapet Road, Kanniakoil, Manapet Village, Bahour Commune, Pondicherry, Pondicherry, Pondicherry, 607402.

Company Details

CIN/LLPIN
U24234PY2002PLC009158
Registration Number
009158
Incorporation Date
24 April 2002
Authorized Capital
₹390.02 Cr
Paid-Up Capital
₹383.51 Cr
ROC Code
Roc Pondicherry
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 390.02 Cr as on 05-01-2026
Paid Up Capital ₹ 383.51 Cr as on 05-01-2026
Company Age 23 Year, 9 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 3.98 Cr as on 05-01-2026
Satisfied Charges ₹ 8.70 Cr as on 05-01-2026
Revenue Growth **** 25.48% (FY 2024)
Profit Growth **** 25.23% (FY 2024)
Ebitda **** -2.57% (FY 2024)
Net Worth -18.20% (FY 2024)
Total Assets -13.82% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Biogenomics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Biogenomics Limited?

Current Directors

Name	Designation	Appointment Date	Status
Pushkar Jauhari	Nominee Director	19 Jun 2022	Current
Rajesh Shashikant Dalal	Director	08 Dec 2023	Current
Rajiv Malik	Additional Director	01 Jul 2025	Current
Namit Rustagi	Director	28 Mar 2022	Current
Ammar Abdullah Hamad Al Ali	Director	28 Mar 2022	Current
Archana Rajesh Krishnan	Whole-Time Director	03 Feb 2006	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	05 Jul 2022	Past
Pramod Abcsdd	Director	28 Mar 2022	Past
Pramod Abcsdd	Director	31 May 2022	Past
Pramod Abcsdd	Director	10 Apr 2010	Past
Pramod Abcsdd	Director	31 May 2022	Past
Pramod Abcsdd	Additional Director	25 Sep 2015	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Biogenomics.

Biogenomics Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 25.48% increase. The company also saw a substantial improvement in profitability, with a 25.23% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.2%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

25.48%

*******

Revenue from Operations

*******

57.87%

*******

Total Assets

*******

-13.82%

*******

Profit or Loss

*******

25.23%

*******

Net Worth

*******

-18.20%

*******

EBITDA

*******

-2.57%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Biogenomics?

In 2024, Biogenomics had a promoter holding of 100.00% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹39,840,000.00

Satisfied Charges

₹87,040,000.00

Charges Breakdown by Lending Institutions

Standard Chartered Bank : 3.98 Cr
Icici Bank Limited : 3.60 Cr
U.C.O. Bank : 1.12 Cr

Latest Charge Details

Date	Lender	Amount	Status
21 Mar 2024	Standard Chartered Bank	₹3.98 Cr	Satisfied
11 Jan 2014	Icici Bank Limited	₹3.60 Cr	Satisfied
10 Oct 2003	U.C.O. Bank	₹1.12 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Biogenomics?

Biogenomics has a workforce of 193 employees as of Dec 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Biogenomics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biogenomics's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Biogenomics

Recent Activity within the Organization

Annual General Meeting

Progress on Biogenomics Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records. was documented.
24 Sep 2025
Charges

Progress on A charge registered on 21 Mar 2024 via Charge ID 100902481 with Standard Chartered Bank was fully satisfied on 20 Aug 2025. was documented.
20 Aug 2025
Director Appointment

Progress on Rajiv Malik was appointed as a Additional Director was appointed as a Additional Director on 01 Jul 2025 & has been associated with this company since 7 months 16 days . was documented.
01 Jul 2025
Balance Sheet

The activity Biogenomics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pondicherry. was completed.
31 Mar 2025
Director Appointment

Imran Jamiluddin Shaikh was appointed as a Nominee Director was appointed as a Nominee Director on 20 Aug 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.
20 Aug 2024
Director Appointment

The activity Shilpa Rakesh Shetty was appointed as a Company Secretary was appointed as a Company Secretary on 08 Apr 2024 & has been associated with this company since 1 year 10 months . was completed.
08 Apr 2024

Explore recent activity and updates - View Recent Activity